MedPath

Effect of Sildenafil on Endometriosis dysmenorrhea

Phase 3
Recruiting
Conditions
endometriosis.
endometriosis
Registration Number
IRCT20140227016765N5
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria

patients with moderate to severe endometriosis suffer from dysmenorrhea,
They are between 18 and 45 years old
They were diagnosed with ultrasound

Exclusion Criteria

People who take nitroglicerine during study
People who have used any hormonal medication
People with hepatorenal disease
People with pelvic pain non relevant to menstural cycle
People with pervious MI or CVA
People with abnormal blood pressure
People with PID
People with malignancies
People with acute eye problem

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before and 1, 2 and 3 hours after the intervention. Method of measurement: VAS questionnaire.
Secondary Outcome Measures
NameTimeMethod
The amount of pain-relieving use during the study. Timepoint: At the end of the study. Method of measurement: questionnaire.
© Copyright 2025. All Rights Reserved by MedPath